Sona Nanotech Inc
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public, Subsidiary
- Established
- 2014-01-01
- Employees
- 10
- Market Cap
- -
- Website
- https://www.sonanano.com
- Introduction
Sona Nanotech Inc is engaged in researching and developing gold nanorod products. It makes products for diagnostic tests and medical treatment applications. The company's product includes Gemini and Saliva tests.
Intratumoral Targeted Hyperthermia Therapy (THT) for Stage 3C/3D/4M1 Cutaneous Metastatic Melanoma
Not Applicable
Not yet recruiting
- Conditions
- Cutaneous Metastatic Melanoma
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Sona Nanotech Inc
- Target Recruit Count
- 10
- Registration Number
- NCT06894407
Intratumoral Targeted Hyperthermia Therapy (THT) for Cutaneous Metastatic Melanoma
Not Applicable
Not yet recruiting
- Conditions
- Cutaneous Metastatic Melanoma
- First Posted Date
- 2025-03-11
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Sona Nanotech Inc
- Target Recruit Count
- 10
- Registration Number
- NCT06870994
Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19
Not Applicable
Completed
- Conditions
- Sars-CoV-2 Infection
- Interventions
- Diagnostic Test: Sona Saliva C-19 Rapid Self-test
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Sona Nanotech Inc
- Target Recruit Count
- 500
- Registration Number
- NCT05256589
- Locations
- 🇨🇦
COVID-19 Assessment centre @bayers lake, Halifax, Nova Scotia, Canada
Performance Study of SONA Saliva C-19 Rapid Test
Not Applicable
Terminated
- Conditions
- Sars-CoV-2 InfectionCorona Virus InfectionCovid19
- Interventions
- Diagnostic Test: Sona Saliva C-19 Rapid Test
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Sona Nanotech Inc
- Target Recruit Count
- 20
- Registration Number
- NCT04877002
- Locations
- 🇨🇦
Humber River Hospital, Toronto, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath